Chang Kochi 4

What Happened

• Chang Kochi, a director of YD Bio Ltd (YDES), had 5,749 restricted share units (RSUs vest) on June 30, 2026. The vested RSUs were converted/exercised into 5,749 ordinary shares and those shares were disposed the same day. The grant associated with these RSUs had an aggregate target grant-date fair value of $60,000 (for the full award granted March 31, 2026).

Key Details

• Transaction date: 2026-06-30; Form 4 filed 2026-07-01 (filed promptly after the transaction).
• Transactions reported: Award/Grant (A) of 5,749 RSUs @ $0.00 (derivative); Conversion/Exercise (M) of 5,749 shares (acquired); Conversion/Exercise (M) of 5,749 shares (disposed) — reported price $0.00 for award and disposal; one acquisition row lists price as N/A.
• Shares involved: 5,749 shares (converted from RSUs). Shares owned after the transaction are not disclosed in the provided excerpt.
• Relevant footnotes:
  • F1: Each RSU represents a contingent right to one ordinary share.
  • F2: The RSUs were granted under the company’s Equity Incentive Plan with an aggregate target grant-date fair value of $60,000; vesting is in four equal quarterly installments, with each installment determined by dividing $15,000 by a 7‑day VWAP prior to vesting.
  • F3: The reporting person became entitled to a fixed number of RSUs on the June 30, 2026 vesting date.
• Filing timeliness: The Form 4 was filed the next day (July 1), within standard SEC timeliness expectations for insider reports.

Context

• These were derivative/award transactions (RSUs vesting and converting to ordinary shares), not open-market purchases or sales. The Form 4 shows the converted shares were disposed the same day; the filing does not state the reason for the disposition (common reasons can include tax withholding or share surrender, but no specific motive is reported).